🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

FACE Phase II (a Stage II Trial)

RecruitingPhase 1, Phase 2Ages 60 Years - 89 YearsAllStanford University
NCT07130669 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

How to ensure adherence to computerized cognitive training in unsupervised circumstances (e.g., at-home, self-administered) in older adults at risk for Alzheimer's disease (AD) or AD related dementia (AD/ADRD) is understudied. The objective of the R33 study is to test a novel facial expression-based personalization engine (FPE) for monitoring and modulating real-time effective engagement, with an ultimate goal of enhancing long-term adherence in unsupervised cognitive training in older adults at risk for AD/ADRD. Here, Effective engagement is defined as the extent to which someone is actively engaged and performing with significant attention and enjoyment while training, addressing a balance between adherence and cognitive gains/plasticity from the training. Based on previous work, the hypotheses include that (1) mental fatigue revealed in facial expressions will reflect a trainee's degr

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. English speaking 2. Aged 60-89 3. Living in a home, or independent- or assisted-living facility 4. Adequate visual and hearing acuity 5. Anti-depressants, antipsychotics, and/or anxiolytics have been stable for at least 7 days 6. Memory medications have been stable for at least 3 months 7. Absence of neurological/vascular disorder (For neurological disorders with minor symptoms check with PI on case-by-case basis) Exclusion Criteria: 1. be enrolled in another intervention study aimed at improving cognition 2. live in nursing home 3. diagnosed with Multiple Sclerosis, TBI, chronic heart failure, Parkinson's disease, dementia
💊

What it tests

  • Cognitive Remediation
  • Cognitive Remediation II
📍

Where

1 site
Stanford University CogT Lab
Palo Alto, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy